Antimicrobial resistance, resulting from overuse of antibiotics, is the greatest threat facing humankind in the 21st century. The RizLab Health mission is to build a point-of-care analyzer that can discriminate between viral and bacterial infections within minutes using only a single drop of blood. RizLab combines micro-chip technology with AI to build a pain-less platform that can within minutes aid physicians determine when their patients need antibiotics.
Upright is on a mission to make delicious foods that are better for people and our planet. Their first product is a category-defining high-protein, allergen-free instant oatmilk in three creamy, delicious flavors: original, vanilla, and chocolate.
Each tasty cup of Upright oatmilk packs the same key nutrients as dairy, without the unwanted allergens or environmental impact. Ready whenever and wherever you want it: just add water!
The TômTex mission is to create innovative material designs that parallel lifecycles observed in nature and serve as alternatives to the production methods that have contributed to our world’s environmental crisis. Our revolutionary bio-based materials offer a sustainable, accessible, and practical alternative to currently available commercial material options.
Increasing awareness of animal agriculture’s impact on the environment together with wider consumer demand for natural health benefits and skepticism over meat supply chains has led to skyrocketing consumer demand for meat alternatives. However, along with higher lab production costs and complexity, the holy grail of taste, texture and relative cost remains elusive. Moreover, health concerns over processing have begun to percolate and questions over actual sustainability and clean labels remain.
Kyomei’s approach grew out of research at the University of Oxford and directly addresses these issues, innovating a novel animal protein production system using internal plant cell biology to produce natural and sustainable animal proteins. Kyomei produces proteins at scale, to power the next generation of meat alternatives.
Pannex Therapeutics is a pioneer biopharmaceutical company totally focused on the development of a novel therapeutic class of Pannexin 1 channel (Panx1) blockers. Pannex is developing a platform of small molecules that blocks this exciting new pharmacological target, Panx1 channels.
With potential applications in many therapeutic areas, the initial focus is on chronic pain treatment. The company is currently developing a first-in-class, selective and highly potent oral Panx1 channel blocker, for the treatment of chronic pain and prevention of opioid addiction.
The cosmetic effects of ageing on skin and the development of skin cancers result from multiple changes in three types of skin cells (fibroblasts, keratinocytes, melanocytes) and degeneration of extracellular components (collagen, elastin). These changes are accelerated by toxic chemicals that are produced in skin when it is exposed to all wavelengths of sunlight, all common atmospheric pollutants, and tobacco smoke.
Kutanios is developing peptides to defend skin against these molecules by sequestering the damaging molecules and promoting their loss during the desquamation of surface cells. As the peptides are completely biodegradable and manufactured by green technology, they also protect the environment while protecting our skin.
Biological sample preparation has not kept pace with the dramatic changes in analytical techniques. Nowhere is this more evident than in DNA sample prep, which continues to be a low throughput process serving high throughput next-generation DNA sequencing. This mismatch is limiting the accelerated uptake of next generation sequencing.
Inso Bio envisions a future of increased accessibility, where complex sample prep protocols are completed from start to finish with the push of a button. This is why we are developing next-generation platforms to streamline workflows leading up to sequencing, to give people more time to devote to science, discovery, and data, rather than wrestling with their samples.
Helex Bio enables gene therapy companies to design gRNAs & simulate outcomes of CRISPR edits to bring effective therapies to market faster with our Helex Platform™. The Helex Platform™ guides gene therapy companies in target identification, design and validation of efficient and safe gRNAs for creating functional impact with minimal significant off-targets. Additionally, the platform simulates edit outcomes to reliably develop therapy protocols.
The Helex Platform™ is powered by intelligent data driven deep-learning modeling using extensive high throughput next generation sequencing data derived from CRISPR edits on human cell lines. Helex not only gives reliable predictions through the Helex Platform™, but validate them in-house using cell-based assays and next generation sequencing to support with proven experimental data for high degree of reliability.
Ceragen is helping global greenhouse vegetable growers improve their plant’s microbiome to increase crop yields. Their first product is a plant growth promoting microbial inoculant that increases tomato yields up to 20% with a single application. Using their automated development pipeline, Ceragen is currently in the process of developing additional inoculants for use in other greenhouse vegetables. Ceragen’s inoculants are designed with the grower in mind, with a specific focus on ease of use and compatibility with all growing media and hydroponic systems.
We all know the over consumption of animal products is a major cause of global warming and environmental degradation, and that the best way we can lower our carbon footprints is to switch to a plant-based diet. However, consumers are compromising on products that are ultra-processed, not necessarily healthy, and lacking variety: today’s meat-alternatives are mostly burgers, sausages & nuggets, and consumers lack ‘whole-muscle’ plant-based products.
The Kinoko Labs solution is to create healthier, nutrient-dense, and minimally processed whole-cut meat-alternatives, grown naturally from mycelium. By leveraging mycelium’s inherent structure, they can naturally replicate the texture of meat without the need for a long list of additives found in current meat alternatives. This means that we can create better-than-meat products that deliver on the entire taste experience, nutrition, and affordability without compromise.